These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 27611455)

  • 21. Recombinant Leishmania major lipophosphoglycan 3 activates human T-lymphocytes via TLR2-independent pathway.
    Hosseini M; Haji Fatahaliha M; Aghebati-Maleki L; Movassagh Pour A; Rafati S; Seifi-Najmi M; Younesi V; Jadidi-Niaragh F; Yousefi M
    J Immunotoxicol; 2016; 13(2):263-9. PubMed ID: 26181511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immunodominant T helper 2 (Th2) response elicited in BALB/c mice by the Leishmania LiP2a and LiP2b acidic ribosomal proteins cannot be reverted by strong Th1 inducers.
    Iborra S; Abánades DR; Parody N; Carrión J; Risueño RM; Pineda MA; Bonay P; Alonso C; Soto M
    Clin Exp Immunol; 2007 Nov; 150(2):375-85. PubMed ID: 17900304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of DNA/DNA and prime-boost vaccination using LPG3 against Leishmania major infection in susceptible BALB/c mice and its antigenic properties in human leishmaniasis.
    Abdian N; Gholami E; Zahedifard F; Safaee N; Rafati S
    Exp Parasitol; 2011 Mar; 127(3):627-36. PubMed ID: 21187087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
    Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG
    J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbon monoxide-releasing molecule-A1 inhibits Th1/Th17 and stimulates Th2 differentiation in vitro.
    Nikolic I; Vujicic M; Stojanovic I; Stosic-Grujicic S; Saksida T
    Scand J Immunol; 2014 Aug; 80(2):95-100. PubMed ID: 24845722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T Helper 1 (Th1), Th2, and Th17 Responses to Leishmania major Lipophosphoglycan 3.
    Miahipour A; Haji-Fatahaliha M; Keshavarz H; Gharavi MJ; Mohamadi H; Babaloo Z; Rafati S; Younesi V; Hosseini M; Yousefi M
    Immunol Invest; 2016 Oct; 45(7):692-702. PubMed ID: 27611455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA; Ogunremi O; Menon JN
    Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery?
    Campos-Neto A
    Braz J Med Biol Res; 2005 Jul; 38(7):979-84. PubMed ID: 16007269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of pro-inflammatory cytokine IL-17 in Leishmania pathogenesis and in protective immunity by Leishmania vaccines.
    Banerjee A; Bhattacharya P; Joshi AB; Ismail N; Dey R; Nakhasi HL
    Cell Immunol; 2016 Nov; 309():37-41. PubMed ID: 27444130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of polarized T helper 1 and T helper 2 cell populations in murine leishmaniasis.
    Coffman RL; Correa-Oliviera R; Mocci S
    Ciba Found Symp; 1995; 195():20-5; discussion 25-33. PubMed ID: 8724828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Th1 concomitant immune response mediated by IFN-γ protects against sand fly delivered Leishmania infection: Implications for vaccine design.
    Seyed N; Rafati S
    Cytokine; 2021 Nov; 147():155247. PubMed ID: 32873468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfer of CD4+ T cells to C.B-17 SCID mice: a model to study Th1 and Th2 cell differentiation and regulation in vivo.
    Powrie F; Coffman RL; Correa-Oliveira R
    Res Immunol; 1994 Jun; 145(5):347-53. PubMed ID: 7701113
    [No Abstract]   [Full Text] [Related]  

  • 33. Differentiation, regulation, and death of T helper cell subsets during infection with Leishmania major.
    Scott P
    Immunol Res; 1998; 17(1-2):229-38. PubMed ID: 9479584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The stability and reversibility of Th1 and Th2 populations.
    Coffman RL; Mocci S; O'Garra A
    Curr Top Microbiol Immunol; 1999; 238():1-12. PubMed ID: 10087647
    [No Abstract]   [Full Text] [Related]  

  • 35. Regulation of T helper cell subsets by cyclooxygenases and their metabolites.
    Li H; Edin ML; Gruzdev A; Cheng J; Bradbury JA; Graves JP; DeGraff LM; Zeldin DC
    Prostaglandins Other Lipid Mediat; 2013; 104-105():74-83. PubMed ID: 23201570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights to structure and immunological features of Leishmania lipophosphoglycan3.
    Hosseini M; Haji-Fatahaliha M; Miahipour A; Yousefi M
    Biomed Pharmacother; 2017 Nov; 95():1369-1374. PubMed ID: 28946184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-MHC-linked genetic polymorphism controls selective development of Th2 but not inhibition of Th1 cells by soluble antigen administration.
    Galbiati F; Adorini L
    Microbes Infect; 1999 Jan; 1(1):73-7. PubMed ID: 10847769
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.